XML 27 R16.htm IDEA: XBRL DOCUMENT

NOTE 9 - SHARE-BASED COMPENSATION

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement, Noncash Expense [Abstract]

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method. For these awards we have recognized compensation expense using a straight-line amortization method reduced for estimated forfeitures.

The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three and nine months ended September 30, 2020 and 2019, respectively, were as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
(in thousands)
Cost of goods sold	$	12	$	6	$	33	$	22
Research and development		87		61		283		227
Selling, general and administrative		267		193		780		662
Total share-based compensation	$	366	$	260	$	1,096	$	911

Equity awards granted during the three and nine months ended September 30, 2020 and 2019 were as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019

Restricted Stock Units		-		-		376,200		276,700
Stock Options		-		-		-		25,000

Non-employee directors Restricted Stock Units (“RSUs”) vest over one year and options vest over three years and have a six-year exercise period. Employee RSUs typically vest over four years and employee Non-Qualified stock options typically vest quarterly over 4 years and have a six-year exercise period.

The remaining unamortized expected future equity compensation expense and remaining amortization period associated with unvested option grants, restricted stock awards and restricted stock unit awards at September 30, 2020 are:

	September 30,2020

Unamortized future equity compensation expense (in thousands)	$	2,413
Remaining weighted average amortization period (in years)		2.46